{
  "EGFR": {
    "receptor_file": "/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/egfr_prepared.pdb",
    "center_x": 29.0,
    "center_y": 6.3,
    "center_z": 54.2,
    "size_x": 25.0,
    "size_y": 25.0,
    "size_z": 25.0,
    "exhaustiveness": 32,
    "num_modes": 20,
    "description": "EGFR kinase domain with erlotinib"
  },
  "BRAF": {
    "receptor_file": "/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/braf_prepared.pdb",
    "center_x": 6.6,
    "center_y": -16.9,
    "center_z": -35.7,
    "size_x": 25.0,
    "size_y": 25.0,
    "size_z": 25.0,
    "exhaustiveness": 32,
    "num_modes": 20,
    "description": "BRAF V600E with vemurafenib"
  },
  "MEK1": {
    "receptor_file": "/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/mek1_prepared.pdb",
    "center_x": -4.64,
    "center_y": 62.39,
    "center_z": 33.77,
    "size_x": 25.0,
    "size_y": 25.0,
    "size_z": 25.0,
    "exhaustiveness": 32,
    "num_modes": 20,
    "description": "MEK1 with U0126"
  }
}